Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47K Buy
+32
New +$4.05K ﹤0.01% 1186
2022
Q3
Sell
-409
Closed -$19K 836
2022
Q2
$19K Hold
409
﹤0.01% 447
2022
Q1
$24K Buy
+409
New +$21.6K ﹤0.01% 437
2021
Q4
Sell
-409
Closed -$20K 290
2021
Q3
$20K Hold
409
﹤0.01% 415
2021
Q2
$35K Hold
409
﹤0.01% 326
2021
Q1
$34K Hold
409
﹤0.01% 308
2020
Q4
$31K Hold
409
﹤0.01% 295
2020
Q3
$20K Hold
409
﹤0.01% 319
2020
Q2
$16K Hold
409
﹤0.01% 324
2020
Q1
$13K Buy
+409
New +$21K ﹤0.01% 344

Other funds holding GKOS

MCF Advisors's GKOS Position: Q2 2026 in Review

MCF Advisors opened a new position in Glaukos (GKOS) in Q2 2026: 32 shares worth $4.47K. The stake represents ﹤0.01% of the portfolio and ranks #1186 among its holdings. This is a return to the name: MCF Advisors previously reported a position in GKOS as recently as Q2 2022.

MCF Advisors first reported a position in GKOS in Q1 2020 and has held it in 10 quarters since. The position peaked at $35K in Q2 2021. 367 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • MCF Advisors held 32 shares of Glaukos worth $4.47K as of Q2 2026.
  • Glaukos was a new MCF Advisors position in Q2 2026.
  • Glaukos made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1186 holding.
  • MCF Advisors first reported a position in Glaukos in Q1 2020 and has held it in 10 quarters since.
  • MCF Advisors's Glaukos position peaked at $35K in Q2 2021.
  • 367 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.